CATALOGO DEI PRODOTTI DELLA RICERCA

QUAGLIA, Francesca Maria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.871
NA - Nord America 2.185
AS - Asia 1.946
SA - Sud America 260
AF - Africa 188
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.470
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.072
RU - Federazione Russa 1.667
SG - Singapore 869
IT - Italia 496
VN - Vietnam 311
CN - Cina 294
BR - Brasile 175
HK - Hong Kong 169
GB - Regno Unito 154
DE - Germania 104
BJ - Benin 87
FR - Francia 79
IN - India 76
SE - Svezia 55
NL - Olanda 54
MX - Messico 50
CA - Canada 43
IE - Irlanda 42
ES - Italia 41
NG - Nigeria 37
PL - Polonia 37
FI - Finlandia 34
JP - Giappone 33
AR - Argentina 29
ID - Indonesia 29
AT - Austria 22
KR - Corea 21
TR - Turchia 21
BD - Bangladesh 20
ZA - Sudafrica 20
TN - Tunisia 18
AU - Australia 16
EC - Ecuador 16
IQ - Iraq 12
RO - Romania 12
PT - Portogallo 11
PH - Filippine 10
PK - Pakistan 10
UA - Ucraina 10
VE - Venezuela 10
CH - Svizzera 9
CO - Colombia 9
IL - Israele 8
SA - Arabia Saudita 8
BE - Belgio 7
CL - Cile 7
HN - Honduras 7
LT - Lituania 7
AE - Emirati Arabi Uniti 6
BG - Bulgaria 6
PS - Palestinian Territory 6
TH - Thailandia 6
GR - Grecia 5
IR - Iran 5
MY - Malesia 5
PY - Paraguay 5
QA - Qatar 5
EG - Egitto 4
ET - Etiopia 4
PE - Perù 4
TG - Togo 4
DO - Repubblica Dominicana 3
LB - Libano 3
MA - Marocco 3
TW - Taiwan 3
UZ - Uzbekistan 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
CG - Congo 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
GE - Georgia 2
GT - Guatemala 2
HR - Croazia 2
JM - Giamaica 2
KE - Kenya 2
KZ - Kazakistan 2
MD - Moldavia 2
MT - Malta 2
NP - Nepal 2
OM - Oman 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
TZ - Tanzania 2
XK - ???statistics.table.value.countryCode.XK??? 2
AZ - Azerbaigian 1
BH - Bahrain 1
BW - Botswana 1
BY - Bielorussia 1
CU - Cuba 1
CY - Cipro 1
DK - Danimarca 1
GY - Guiana 1
HU - Ungheria 1
JO - Giordania 1
KW - Kuwait 1
MU - Mauritius 1
NC - Nuova Caledonia 1
Totale 7.463
Salva come PNG Salva come JPEG
Città #
Moscow 716
San Jose 539
Singapore 519
Ashburn 381
Verona 223
Hong Kong 163
Dallas 162
Ho Chi Minh City 97
Chandler 96
Cotonou 87
Los Angeles 74
Hanoi 71
New York 71
Beijing 68
Orem 48
Milan 41
Buffalo 40
Dublin 40
London 37
The Dalles 36
São Paulo 32
Warsaw 32
Mexico City 27
Chennai 26
Tokyo 26
Council Bluffs 24
Montreal 23
Xi'an 23
Denver 22
Munich 21
Santa Clara 21
Brooklyn 20
Stockholm 20
Abuja 19
Houston 19
Atlanta 18
Haiphong 18
Helsinki 18
Lagos 18
Da Nang 17
Poplar 17
Jacksonville 15
Johannesburg 15
Frankfurt am Main 14
Jakarta 14
Querétaro 14
Southend 14
Manchester 13
Amsterdam 12
Mumbai 12
Seattle 12
Falkenstein 11
Melbourne 11
Phoenix 11
Bologna 10
Boston 10
Bucharest 10
Lawrence 10
Lisbon 10
Madrid 10
Padua 10
Princeton 10
Rome 10
Stuttgart 10
Toronto 10
Wilmington 10
Boardman 9
Tianjin 9
Vienna 9
Ankara 8
City of London 8
Dong Ket 8
Jinan 8
Lappeenranta 8
Redondo Beach 8
Columbus 7
Hürth 7
Ninh Bình 7
Tunis 7
Chicago 6
Guangzhou 6
Guayaquil 6
New Delhi 6
Nuremberg 6
Paris 6
Brussels 5
Bắc Ninh 5
Dhaka 5
Doha 5
Hyderabad 5
Hải Dương 5
Istanbul 5
Marseille 5
Norwalk 5
Plovdiv 5
Quito 5
Raleigh 5
Rio de Janeiro 5
Santiago 5
Seoul 5
Totale 4.472
Salva come PNG Salva come JPEG
Nome #
B-cell receptor signaling activity identifies patients with mantle cell lymphoma at higher risk of progression 211
Fentanyl buccal tablet: a new breakthrough pain medication in early management of severe vaso-occlusive crisis in sickle cell disease. 201
Chronic lymphocytic leukemia and mantle cell lymphoma: similarities and differences from an integrated biological and clinical approach 200
The rs1001179 SNP and CpG methylation regulate catalase expression in chronic lymphocytic leukemia 192
Outcomes in first relapsed-refractory younger patients with mantle cell lymphoma: results from the MANTLE-FIRST study 181
Notch Signaling Molecules as Prognostic Biomarkers for Acute Myeloid Leukemia 174
Efficacy of R-COMP in comparison to R-CHOP in patients with DLBCL: A systematic review and single-arm metanalysis 169
Allogeneic stem cell transplantation in patients with mantle cell lymphoma: results from the MANTLE-FIRST study on behalf of Fondazione Italiana Linfomi 164
Oncogenic Mutations of MYD88 and CD79B in Diffuse Large B-Cell Lymphoma and Implications for Clinical Practice 160
A real-life study of daratumumab-bortezomib-dexamethasone (D-VD) in lenalidomide exposed/refractory multiple myeloma patients: a report from the Triveneto Myeloma Working Group 158
Functional dosing of mesenchymal stromal cell-derived extracellular vesicles for the prevention of acute graft-versus-host-disease 157
Bendamustine plus rituximab: is it a BRIGHT idea? 139
Pembrolizumab as salvage treatment for T-cell/histiocyte-rich and Epstein-Barr virus-positive large B-cell lymphoma 137
CAT rs1001179 Single Nucleotide Polymorphism Identifies an Aggressive Clinical Behavior in Chronic Lymphocytic Leukemia 136
Outcomes of younger patients with mantle cell lymphoma experiencing late relapse (>24 months): the LATE-POD study 122
Efficacy of R-BAC in relapsed, refractory mantle cell lymphoma post BTK inhibitor therapy 118
Mantle cell lymphoma patients in first relapse: we pretty much know what to do 107
T CELL/HISTIOCYTE-RICH LARGE B-CELL LYMPHOMA: CLINICO-PATHOLOGICAL FEATURES AND RESPONSE TO IMMUNE CHECKPOINT INHIBITORS 105
Differential diagnosis of lymphocytosis in routine laboratory practice: the contribution of Sysmex- XN9100 101
GENOMIC ANALYSES OF PATIENTS WITH MANTLE CELL LYMPHOMA THAT WERE REFRACTORY OR RELAPSED AFTER INDUCTION THERAPY: RESULTS FROM THE FIL_MANTLE- FIRST BIO STUDY 95
Visceral Leishmaniasis Following A+AVD Treatment in a Patient with Classical Hodgkin's Lymphoma: A Case Report and Review of the Literature 95
CATALASE BLOCKING INDUCES APOPTOSIS AND POTENTIATES VENETOCLAX-INDUCED CELL DEATH IN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS 89
IBRUTINIB DOSE MODIFICATION IN MANTLE CELL LYMPHOMA: AN ITALIAN REAL-LIFE MULTICENTER EXPERIENCE. RESULTS FROM THE REDOT_MCL STUDY 86
SCOPING OUT CARDIOVASCULAR ASSESSMENT ON INITIATION AND SUBSEQUENT MONITORING DURING BTKI THERAPY, AN ERIC INITIATIVE 76
THE ROLE OF STEM CELL TRANSPLANTATION AS CONSOLIDATION THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA TREATED WITH CHECKPOINT INHIBITORS: ITALIAN MULTICENTER EXPERIENCE 74
THE ROLE OF STEM CELL TRANSPLANTATION IN PATIENTS WITH R/R CLASSICAL HODGKIN LYMPHOMA TREATED WITH CHECKPOINT INHIBITORS: ITALIAN MULTICENTER EXPERIENCE 72
FITNESS STATUS AND TIME TO FIRST PROGRESSION IN ELDERLY PATIENTS WITH MANTLE CELL LYMPHOMA: RESULTS FROM THE “ELDERLY MANTLE-FIRST” STUDY 71
A phospho-specific flow cytometry study reveals the impact of BCR signaling activation in mantle cell lymphoma progression and therapy 69
ACTIVATION OF BCR SIGNALING REWIRES THE RESPONSE OF BCR-ASSOCIATED KINASES TO IBRUTINIB IN MANTLE CELL LYMPHOMA CELLS 68
IN CHRONIC LYMPHOCYTIC LEUKAEMIA WITH COMPLEX KARYOTYPE, MAJOR STRUCTURAL ABNORMALITIES IDENTI- FY A SUBSET OF PATIENTS WITH INFERIOR OUTCOME AND DISTINCT BIOLOGIC CHARACTERISTICS 68
GENETIC AND EPIGENETIC MECHANISMS REGULATING CATALASE EXPRESSION IN CHRONIC LYMPHOCYTIC LEUKEMIA 67
Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations 66
THE PROGNOSTIC ROLE OF DEL 9P21.3 (CDKN2A) IN PATIENTS WITH MANTLE CELL LYMPHOMA. RESULTS FROM THE FIL_MANTLE-FIRST BIO STUDY 65
CAT RS1001179 SINGLE NUCLEOTIDE POLYMORPHISM IDENTIFIES AN AGGRESSIVE CLINICAL BEHAVIOR IN CHRONIC LYMPHOCYTIC LEUKEMIA 64
B-CELL RECEPTOR SIGNALING PROFILES IN MANTLE CELL LYMPHOMA: A BARCODING AND PHOSPHO-SPECIFIC FLOW CYTOMETRY APPROACH 64
OUTCOME OF 100 TP53-DISRUPTED CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS TREATED FRONT-LINE WITH IBRUTINIB. A REAL-LIFE CAMPUS CLL STUDY. 63
BCR signaling activity stratifies patents with MCL with divergent clinical outcome 62
B-CELL RECEPTOR SIGNALING ACTIVITY IDENTIFIES PATIENTS WITH MANTLE CELL LYMPHOMA AT HIGHER RISK OF PROGRESSION 62
A MULTI‐CENTER REAL‐LIFE ANALYSIS ON PATIENTS WITH LARGE B‐CELL LYMPHOMA AFTER FAILURE OF CAR‐T CELLS THERAPY 60
An Observational Study on Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Treated with Venetoclax-Based Regimens Outside Clinical Trials in Italy (GIMEMA CLL1920) 59
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 58
Response to ibrutinib of a refractory IgA lymphoplasmacytic lymphoma carrying the MYD88 L265P gene mutation. 58
A MULTI-CENTER REAL-LIFE ANALYSIS ON PATIENTS WITH LARGE B-CELL LYMPHOMA AFTER FAILURE OF CAR-T CELLS THERAPY 58
Differences in Clinical Course and Management of Sars-CoV2 Infection in Patients with Chronic Lymphocytic Leukemia between the Sequential Pandemic Phases: An Eric Study 57
THE PROGNOSTIC SIGNIFICANCE OF MYC AND BCL2 PROTEIN DOUBLE EXPRESSION IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA, NOS, IN THE ABSENCE OF MYC REARRANGEMENT 57
B-CELL RECEPTOR SIGNALING PROFILES IDENTIFY SUBSETS OF MANTLE CELL LYMPHOMA PATIENTS WITH DIFFERENT CLINICAL OUTCOMES 56
Chronic lymphocytic leukemia management in Italy during the COVID-19 pandemic: a Campus CLL report 55
A REAL-LIFE STUDY OF DARATUMUMAB-BORTEZOMIB-DEX- AMETHASONE (DVD) IN LENALIDOMIDE EXPOSED/REFRAC- TORY MULTIPLE MYELOMA PATIENTS: A REPORT FROM THE MYELOMA TRIVENETO WORKING GROUP 55
Different infiltration patterns within the tumor microenvironment can identify mantle cell lymphoma patients with different clinical outcomes. Results from a pilot clinical-pathological study 54
Association of genetic polymorphisms with differential catalase gene expression in prognostic groups of chronic lymphocytic leukemia patients. 53
Callosal agenesis in craniofrontonasal dysplasia 52
Validation of Argo (Automatic record generator for Onco-Hematology), a New App Supporting the Automatic Conversion of Paper-Based Pathology Reports in Standardized Ecrfs 52
A MULTI-CENTER REAL-LIFE ANALYSIS ON PATIENTS WITH LARGE B-CELL LYMPHOMA AFTER FAILURE OF CAR-T CELLS THERAPY 52
VENETOCLAX IN MULTI-RELAPSED MANTLE CELL LYMPHOMA PATIENTS: A REAL-LIFE MULTICENTRIC EXPERIENCE 51
R-BAC Maintains High Response Rate in Mantle Cell Lymphoma Following Relapse on BTK Inhibitor Therapy 51
Worldwide Examination of Patients with CLL Hospitalized for COVID-19 51
Retrospective Real-Life Comparison of Obinutuzumab Plus Chlorambucil Versus Ibrutinib in Previously Untreated and Unfit Patients with Chronic Lymphocytic Leukemia without TP53 Disruptions. Interim Results from the Italian CLL Campus 51
Minimal Residual Disease Evaluation in the Context of V-Rbac, a Risk-Tailored Phase II Trial of the Fondazione Italiana Linfomi (FIL) 50
Continuous treatment with Ibrutinib in 100 untreated patients with TP53 disrupted chronic lymphocytic leukemia: A real‐life campus CLL study 50
Atherosclerotic ectasia of coronary arteries 50
THE ROLE OF STEM CELL TRANSPLANTATION IN PATIENTS WITH RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA TREATED WITH CHECKPOINT INHIBITORS: ITALIAN MULTICENTER EXPERIENCE 49
ARGO, AUTOMATIC RECORD GENERATOR IN ONCOLOGY: MULTICENTRIC VALIDATION OF A NEW TOOL FOR AUTO- MATIC CONVERSION OF “REAL-LIFE” HEMOLYMPHOPATHOL- OGY REPORTS IN STANDARDIZED ECRF 49
Paraaortic PEComa 49
Outcomes of younger patients with mantle‐cell lymphoma experiencing late relapse (>24 months): the LATE‐POD study 49
IBRUTINIB DOSE MODIFICATION IN MANTLE CELL LYMPHOMA: AN ITALIAN REAL‐LIFE MULTICENTER EXPERIENCE. RESULTS FROM THE REDOT_MCL STUDY 49
Recurrent infiltrative cancer of the cheek: a case report 47
CATALASE EXPRESSION IN LEUKEMIA CELLS IS CONTROLLED BY GENETIC AND EPIGENETIC MECHANISMS 46
OBINUTUZUMAB PLUS CHLORAMBUCIL VERSUS IBRUTINIB IN PREVIOUSLY UNTREATED PATIENTS WITH CHRONIC LYM- PHOCYTIC LEUKEMIA WITHOUT TP53 DISRUPTIONS. A CAMPUS CLL STUDY 45
Simultaneous abdominal histoplasmosis and cerebral toxoplasmosis in an AIDS patient 45
AN EXTENSIVE MOLECULAR CYTOGENETIC CHARACTERIZATION IN HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA IDENTIFIES KARYOTYPE ABERRATIONS AND TP53 DISRUPTION AS PREDICTORS OF OUTCOME AND CHEMOREFRACTORINESS 45
RESPONSE TO IBRUTINIB OF AN AGGRESSIVE IG-A LYMPHOPLASMACYTIC LYMPHOMA CARRYING THE MYD88 L265P GENE MUTATION 45
Fluorescent cell barcoding and phospho-specific flow cytometry characterize B-cell receptor signaling profiles associated with different clinical outcome in mantle cell lymphoma 45
Diagnosis of groove pancreatitis in patient with chronic pancreatitis and recurrent abdominal pain 44
Regulation of catalase gene expression in chronic lymphocytic leukemia patients. 44
VALIDATION OF AN INFECTION RISK SYSTEM IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA TREATED WITH THE IDELALISIB-RITUXIMAB REGIMEN 44
Brachial aneurysm following arterovenous fistula ligation 44
Rituximab, bendamustine, and cytarabine followed by venetoclax in older patients with high-risk mantle cell lymphoma (FIL_V-RBAC): a multicentre, single-arm, phase 2 study 43
Electronic case report forms generation from pathology reports by ARGO, automatic record generator for onco-hematology 43
Cavernous sinus thrombosis: exophtalmos in a patient with Internal Carotid Artery (ICA) aneurysm 43
The role of time to first progression and fitness status in elderly patients with mantle cell lymphoma: results from the ELDERLY MANTLE-FIRST study 43
Gastroepiploic artery bypass graft 43
COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus 43
Left main coronary artery aneurysm 42
Notch signaling is a poor prognostic factor in Acute Myeloid Leukemia (AML). 42
The presentation of a possible effect induced by human contact with a source of high voltage electrical current 41
PROGNOSTIC AND PREDICTIVE SIGNIFICANCE OF THE B-CELL RECEPTOR SIGNALING IN MANTLE CELL LYMPHOMA 41
Subacute combined degeneration 40
Ultrasound guided radiofrequency thermoablation of thyroid substernal goiter 39
In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics 39
HBV REACTIVATION IN CLL PATIENTS WITH OCCULT HBV INFECTION TREATED WITH IBRUTINIB WITH OR WITHOUT VIRAL PROPHYLAXIS. A RETROSPECTIVE MULTICENTRIC GIMEMA STUDY 39
DIFFERENT MICROENVIRONMENTAL PATTERNS OF T-CELL INFILTRATION CAN IDENTIFY MANTLE CELL LYMPHOMA PATIENTS WITH DISTINCT CLINICAL OUTCOMES. RESULTS FROM A PILOT CLINICAL-PATHOLOGICAL STUDY 38
Correction: Outcomes in first relapsed-refractory younger patients with mantle cell lymphoma: results from the MANTLE-FIRST study 38
Response to ibrutinib of refractory life-threatening autoimmune hemolytic anemia occurring in a relapsed chronic lymphocytic leukemia patient with 17p deletion 37
Squamous cell carcinoma of the penis: a case report 37
Preoperative visualisation of Adamkiewicz artery by computed tomography in a patient with aortic aneurysm 37
Biological significance and prognostic/predictive impact of complex karyotype in chronic lymphocytic leukemia 37
Extensive NGS analysis in untreated CLL patients: clinical and biological correlations 37
COMPARISON OF EEG-FMRI DATA TO INVASIVE ELECTROPHYSIOLOGICAL REGISTRATION IN CRYPTOGENIC FOCAL EPILEPSY 36
COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study 35
Efficacy of idelalisib and rituximab in relapsed/refractory chronic lymphocytic leukemia treated outside of clinical trials. A report of the Gimema Working Group 34
Totale 7.184
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.796
article - articoli 11.338
book - libri 0
conference - conferenze 4.576
curatela - curatele 0
other - altro 1.882
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.592
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202118 0 0 0 0 0 0 0 0 0 2 4 12
2021/202279 2 19 0 5 11 5 0 4 3 3 6 21
2022/2023265 10 31 23 43 23 70 0 25 23 1 9 7
2023/2024192 7 6 10 18 26 29 12 17 11 17 28 11
2024/2025636 21 30 48 93 29 23 39 63 74 38 64 114
2025/20266.334 83 137 129 779 2.707 590 604 495 512 298 0 0
Totale 7.605